首頁 > 市場調查報告書 > 醫療設備

病患監測呼吸器

智慧氣喘監測設備市場規模、佔有率及成長分析（按產品、應用及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900458

智慧氣喘監測設備市場規模、佔有率及成長分析（按產品、應用及地區分類）－2026-2033年產業預測

Intelligent Asthma Monitoring Devices Market Size, Share, and Growth Analysis, By Product (Wearable Asthma Monitoring Devices, Smart Inhalers), By End Use (Hospitals, Clinics), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球智慧氣喘監測設備市場規模預計到 2024 年將達到 8.1133 億美元，從 2025 年的 10.1903 億美元成長到 2033 年的 63.1106 億美元，在預測期（2026-2033 年）內複合年成長率為 25.6%。

由於空氣污染日益嚴重、人們對室內污染物的敏感性增加以及慢性阻塞性肺病（COPD）和氣喘盛行率上升，智慧氣喘監測設備市場正經歷顯著成長。推動這一成長的關鍵因素包括智慧吸入器的日益普及、以患者為中心的醫療模式的轉變以及製藥公司和醫療器材製造商之間合作的加強。醫療保健領域的先進數位設備旨在提醒用戶潛在的氣喘發作，並監測用藥依從性和追蹤用藥時間。行動醫療應用程式、穿戴式裝置和個人監測工具的整合展現出巨大的潛力，有望改善氣喘管理，最終有助於提高氣喘患者的治療效果和生活品質。

全球智慧氣喘監測設備市場促進因素

全球污染程度顯著上升是氣喘盛行率不斷攀升的主要因素，也因此推動了對智慧氣喘監測設備的需求。包括氣喘在內的慢性呼吸系統疾病影響著全球數百萬人口，這使得先進的監測解決方案變得至關重要。人們對這些設備益處的認知不斷提高，加之技術的快速發展和產業關注度的提升，進一步推動了市場擴張。智慧吸入器，例如乾粉吸入器和定量噴霧吸入器，正受到希望加強氣喘管理和提高藥物療效的主要企業的青睞。這種日益成長的認知和創新對於支撐不斷變化的市場格局至關重要。

限制全球智慧氣喘監測設備市場的因素

全球污染日益加劇，導致氣喘發病率不斷上升，凸顯了對價格合理、技術先進的監測設備的迫切需求，這些設備能夠鼓勵患者積極參與自我護理。然而，大眾對智慧吸入器和霧化器的功能和益處認知不足，阻礙了全球智慧氣喘監測設備市場的發展。這種認知差距使得患者無法充分利用這些創新工具，進而影響氣喘管理和健康狀況的改善。彌合這一認知差距對於市場擴張和提升患者照護至關重要。

全球智慧型氣喘監測設備市場趨勢

隨著人們對呼吸系統健康的日益關注以及氣喘在全球範圍內的盛行率不斷上升，全球智慧氣喘監測設備市場正經歷顯著成長。諸如智慧型貼片等創新產品代表市場的發展趨勢，其採用的先進穿戴式技術能夠持續監測咳嗽、呼吸頻率和喘息等症狀。這些智慧型設備不僅透過震動回饋提醒用戶注意異常情況，還能透過通知功能幫助用戶與看護者及時溝通。隨著消費者越來越重視個人化的健康管理解決方案，對高度互聯且易於使用的氣喘監測技術的需求激增，推動了市場擴張，並促進了呼吸系統疾病預防保健的轉變。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Adherium Limited（New Zealand）
AstraZeneca plc（United Kingdom）
Boehringer Ingelheim International GmbH（Germany）
Cohero Health, Inc.（United States）
GlaxoSmithKline plc（United Kingdom）
Health Care Originals, Inc.（United States）
Koninklijke Philips NV（Netherlands）
Teva Pharmaceutical Industries Ltd.（Israel）
Vectura Group plc（United Kingdom）
Volansys Technologies Pvt. Ltd.（India）
3M（United States）
AEvice Health（Singapore）
Respiri Limited（Australia）
Quvium（United States）
Findair（Poland）
Sensirion AG（Switzerland）
Thorasys Thoracic Medical Systems Inc.（Canada）
Vitalograph Ltd.（Ireland）
Zephyr Sleep Technologies（Canada）

結論與建議

簡介目錄

Product Code: SQMIG35C2023

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 811.33 Million in 2024 and is poised to grow from USD 1019.03 Million in 2025 to USD 6311.06 Million by 2033, growing at a CAGR of 25.6% during the forecast period (2026-2033).

The market for intelligent asthma monitoring devices is experiencing notable growth driven by rising air pollution, increasing sensitivity to indoor pollutants, and the escalating prevalence of COPD and asthma. Key factors fostering this expansion include the growing adoption of smart inhalers, the shift toward patient-centered healthcare models, and enhanced collaboration between pharmaceutical firms and device manufacturers. Advanced digital devices in healthcare are designed to alert users to potential asthma attacks, while also monitoring medication adherence and tracking dosing times. The integration of mobile health applications, wearables, and personal monitoring tools underscores the significant potential for improving asthma management, ultimately contributing to better patient outcomes and enhanced quality of life for individuals living with asthma.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intelligent Asthma Monitoring Devices Market Segments Analysis

Global Intelligent Asthma Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into wearable asthma monitoring devices, smart inhalers, inhalers, dry powdered inhalers (DPI's), metered dose inhalers (MDI's) and nebulizers. Based on end use, the market is segmented into hospitals, clinics, home use and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intelligent Asthma Monitoring Devices Market

The significant rise in global pollution levels is a primary driver for the increasing prevalence of asthma, leading to heightened demand for intelligent asthma monitoring devices. Chronic respiratory issues, including asthma, affect millions globally, prompting a critical need for advanced monitoring solutions. The awareness regarding the benefits of these devices, coupled with rapid technological advancements and heightened industry focus, is further stimulating market expansion. Smart inhalers, such as dry powdered inhalers and metered dose inhalers, are gaining traction among leading companies aiming to enhance asthma management and improve medication efficacy. This growing recognition and innovation is crucial for supporting the evolving market landscape.

Restraints in the Global Intelligent Asthma Monitoring Devices Market

The increasing pollution levels worldwide contribute to a higher incidence of asthma, highlighting the urgent demand for affordable and advanced monitoring devices to encourage patients to actively engage in their self-care routines. However, the growth of the global intelligent asthma monitoring devices market is hindered by a general lack of awareness regarding the functionality and benefits of smart inhalers and nebulizers. This gap in understanding prevents patients from fully utilizing these innovative tools, which could otherwise enhance their asthma management and overall health outcomes. Addressing this knowledge deficiency is crucial for the market's expansion and the improvement of patient care.

Market Trends of the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market is experiencing significant growth as a result of rising awareness regarding respiratory health and the increasing prevalence of asthma worldwide. Innovations such as the ADAMM smart patch exemplify the market's evolution with advanced wearables that continuously monitor symptoms like cough, respiration rate, and wheezing. These intelligent devices not only alert users to deviations from normal patterns through vibrational feedback but also facilitate timely communication with caregivers via notifications. As consumers prioritize personalized health management solutions, the demand for connected, user-friendly asthma monitoring technologies is surging, driving market expansion and fostering a shift toward proactive respiratory care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis

Global Intelligent Asthma Monitoring Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Wearable Asthma Monitoring Devices
Smart Inhalers
Inhalers
Dry Powdered Inhalers (DPI's)
Metered Dose Inhalers (MDI's)
Nebulizers

Global Intelligent Asthma Monitoring Devices Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Home Use
Others

Global Intelligent Asthma Monitoring Devices Market Size & CAGR (2026-2033)

North America (Product, End Use)
- US
- Canada
Europe (Product, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Adherium Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohero Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Care Originals, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Volansys Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AEvice Health (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Respiri Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quvium (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Findair (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensirion AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thorasys Thoracic Medical Systems Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitalograph Ltd. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zephyr Sleep Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments